News Sentiment

ONCY sentiment intelligence

Oncolytics Biotech Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 41 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.89 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 33

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-1.3% over one week, +10.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY)

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend inactive 10.5% over four weeks
Fair value -19.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 36
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 33
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
GlobeNewswire 7
simplywall.st 7
Stock Titan 5
PR Newswire 3
MT Newswires 2
GuruFocus 1
MarketBeat 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 9
Regulatory and legal 1
Guidance 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-41 of 41